Over the next decade, several longer-acting versions were developed, including: Victoza (liraglutide) approved in 2010 Bydureon approved in 2012 Trulicity approved in 2014 During this period the medications were primarily prescribed for diabetes , and awareness outside medical circles was relatively limited
Tirzepatide may also be unsuitable if you have a history of pancreatitis, severe gastrointestinal disease, or if you are pregnant or breastfeeding
Resources and biological activities of natural polyphenols
Roughly half of the participants lost 15% of their weight or more
If oral supplements are not sufficient or absorption is compromised, periodic B12 injections may be recommended by our healthcare providers
Compounded GLP-1 medications As demand for these medications surges, some patients and healthcare providers have turned to compounded versions of GLP-1 drugs